跳至主要内容
临床试验/NCT06296316
NCT06296316终止不适用

Real-Life Use of Transabdominal Restorelle® Meshes in Apical Prolapse Repair: an Observational Post-Market Clinical Study

Coloplast A/S6 个研究点 分布在 1 个国家目标入组 39 人开始时间: 2023年11月21日最近更新:
适应症

试验速览

阶段
不适用
状态
终止
发起方
Coloplast A/S
入组人数
39
试验地点
6
主要终点
The incidence rate of a surgical reintervention related to Restorelle mesh use over at least the 5 first years of post-index procedure follow-up

研究概览

简要总结

The purpose of this study is to prospectively follow patients after a sacrocolpopexy with Restorelle® mesh for apical prolapse repair as part of routine care. It will help to describe the safety profile and to confirm the clinical benefits of Restorelle mesh for at least 5 to 8 years post-surgery.

详细描述

This study is a non-interventional, multicenter and post market clinical follow-up in adult women with apical prolapse under normal conditions of use (after a sacrocolpopexy with Restorelle mesh for apical prolapse repair as part of routine care). The patient will be followed for 1 year (or less) by the investigator as per local usual practice. At the same time, the patient will be followed via PRO (Patient Reported Outcomes) over a period of 5 to 8 years.

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Prospective

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
Female
接受健康志愿者

入选标准

  • Female patient of at least 18 years old
  • Patient presenting apical pelvic organ prolapse and being eligible to surgical treatment
  • Surgeon having decided to treat the patient with a Restorelle mesh as per its CE mark indication and IFU, before patient inclusion
  • Patient having received appropriate information and counselling before mesh implantation
  • Patient has been provided written informed consent

排除标准

  • Patient currently pregnant or breastfeeding
  • Patient being deprived of liberty by a judicial or administrative decision, or who is under a measure of legal protection

结局指标

主要结局

The incidence rate of a surgical reintervention related to Restorelle mesh use over at least the 5 first years of post-index procedure follow-up

时间窗: up to 5 years

次要结局

  • Number of patients who have only had surgical reintervention not related to Restorelle mesh use(through study completion, at least 5 and up to 8 years)
  • Number of patients who have had more than 1 surgical reintervention (unrelated to mesh use)(5 years ; up to 8-year after index procedure)
  • Number of Restorelle mesh Device Deficiencies(through study completion, at least 5 and up to 8 years)
  • Incidence rate of surgical reintervention related to Restorelle mesh use in patients(through study completion, at least 5 and up to 8 years)
  • Percentage of patients who have had more than 1 surgical reintervention (unrelated to mesh use)(5 years ; up to 8-year after index procedure)
  • Description of Restorelle mesh Device Deficiencies(through study completion, at least 5 and up to 8 years)
  • Monitoring of postoperative pain related to Restorelle mesh use using the modified TOMUS/PREM questionnaire(through study completion, at least 5 and up to 8 years)
  • Changes of prolapse symptoms(Pre-index procedure ; 2 months ; 12 months ; Every year (at least 5 and up to 8 years))
  • Patient impression of improvement of surgical reintervention assessed by the PGI-I-Reintervention(6 months after surgical reintervention)
  • Assessment of the sexual functioning by the changes in dyspareunia status of patients who are sexually active.(Pre-index procedure ; 12 months)
  • Percentage of patients who have only had surgical reintervention not related to Restorelle mesh use(through study completion, at least 5 and up to 8 years)
  • Description of patients who have had more than 1 surgical reintervention (unrelated to mesh use)(5 years ; up to 8-year after index procedure)
  • Percentage of Adverse Device Effect(through study completion, at least 5 and up to 8 years)
  • Percentage of Restorelle mesh Device Deficiencies(through study completion, at least 5 and up to 8 years)
  • Prolapse symptoms - number(12 months ; 5 years)
  • Number of patients defining success via patient global impression of improvement (PGI-I) scale(2 months ; 12 months ; Every year (at least 5 and up to 8 years))
  • Number of Adverse Device Effect(through study completion, at least 5 and up to 8 years)
  • Prolapse symptoms - percentage(12 months ; 5 years)
  • Assessment of health related quality of life using the EQ-5D-5L questionnaire(Pre-index procedure ; 2 months ; 12 months ; Every year (at least 5 and up to 8 years))
  • Assessment of health related quality of life using the PFIQ-7 questionnaire(Pre-index procedure ; 2 months ; 12 months ; Every year (at least 5 and up to 8 years))
  • Assessment of the sexual functioning by the PISQ-IR questionnaire(Pre-index procedure ; 2 months ; 12 months ; Every year (at least 5 and up to 8 years))
  • Percentage of patients defining success via patient global impression of improvement (PGI-I) scale(2 months ;12 months ; Every year (at least 5 and up to 8 years))
  • Percentage of patients satisfied after the index procedure as assessed by the Surgical Satisfaction Questionnaire (SSQ-8)(2 months ; 12 months ; Every year (at least 5 and up to 8 years))
  • Number of patients satisfied after the index procedure as assessed by the Surgical Satisfaction Questionnaire (SSQ-8).(2 months ; 12 months ; Every year (at least 5 and up to 8 years))

研究者

发起方
Coloplast A/S
申办方类型
Industry
责任方
Sponsor

研究点 (6)

Loading locations...

相似试验